$AGX
ARGAN INC

2021 Q1 Form 10-K Financial Statement

#000155837021004282 Filed on April 14, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1 2019 Q1
Revenue $117.2M $68.00M $87.70M
YoY Change 72.35% -22.46% -48.29%
Cost Of Revenue $95.20M $62.70M $80.90M
YoY Change 51.83% -22.5% -45.89%
Gross Profit $22.10M $5.200M $6.700M
YoY Change 325.0% -22.39% -66.67%
Gross Profit Margin 18.86% 7.65% 7.64%
Selling, General & Admin $10.20M $12.40M $9.500M
YoY Change -17.74% 30.53% -16.67%
% of Gross Profit 46.15% 238.46% 141.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.100M $1.100M $1.100M
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit 4.98% 21.15% 16.42%
Operating Expenses $10.20M $12.40M $9.600M
YoY Change -17.74% 29.17% -15.04%
Operating Profit $11.90M -$7.200M -$2.900M
YoY Change -265.28% 148.28% -132.95%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $100.0K $600.0K $1.900M
YoY Change -83.33% -68.42% 35.71%
Pretax Income $12.00M -$9.300M -$2.400M
YoY Change -229.03% 287.5% -125.0%
Income Tax $2.500M -$2.100M -$100.0K
% Of Pretax Income 20.83%
Net Earnings $9.600M -$7.200M -$2.200M
YoY Change -233.33% 227.27% -131.43%
Net Earnings / Revenue 8.19% -10.59% -2.51%
Basic Earnings Per Share
Diluted Earnings Per Share $603.8K -$461.5K -$139.2K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $456.7M $327.9M $296.5M
YoY Change 39.28% 10.59% -31.68%
Cash & Equivalents $366.7M $167.4M $164.3M
Short-Term Investments $90.10M $160.5M $132.2M
Other Short-Term Assets $34.15M $23.32M $25.30M
YoY Change 46.41% -7.82% 132.11%
Inventory
Prepaid Expenses
Receivables $28.71M $37.19M $94.50M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $546.2M $421.8M $416.3M
YoY Change 29.51% 1.3% -14.16%
LONG-TERM ASSETS
Property, Plant & Equipment $20.36M $22.54M $19.80M
YoY Change -9.66% 13.83% 29.41%
Goodwill $27.94M $27.94M $32.84M
YoY Change 0.0% -14.91% -4.34%
Intangibles $4.097M $5.001M
YoY Change -18.08%
Long-Term Investments
YoY Change
Other Assets $200.0K $8.300M $1.500M
YoY Change -97.59% 453.33% 66.67%
Total Long-Term Assets $56.41M $65.79M $60.30M
YoY Change -14.25% 9.1% 4.51%
TOTAL ASSETS
Total Short-Term Assets $546.2M $421.8M $416.3M
Total Long-Term Assets $56.41M $65.79M $60.30M
Total Assets $602.6M $487.5M $476.6M
YoY Change 23.61% 2.29% -12.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.30M $35.44M $39.90M
YoY Change 50.37% -11.17% -60.18%
Accrued Expenses $50.75M $35.91M $33.10M
YoY Change 41.34% 8.48% -6.5%
Deferred Revenue $172.0M $72.69M
YoY Change 136.7%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $276.1M $144.0M $81.32M
YoY Change 91.68% 77.13% -55.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.135M $2.476M $1.000M
YoY Change 67.0% 147.6%
Total Long-Term Liabilities $4.135M $2.476M $1.000M
YoY Change 67.0% 147.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $276.1M $144.0M $81.32M
Total Long-Term Liabilities $4.135M $2.476M $1.000M
Total Liabilities $280.2M $146.5M $82.10M
YoY Change 91.26% 78.45% -55.53%
SHAREHOLDERS EQUITY
Retained Earnings $166.1M $189.3M
YoY Change -12.25%
Common Stock $155.7M $151.1M
YoY Change 3.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $33.00K
YoY Change
Treasury Stock Shares $3.233K
Shareholders Equity $320.7M $339.2M $394.6M
YoY Change
Total Liabilities & Shareholders Equity $602.6M $487.5M $476.6M
YoY Change 23.61% 2.3% -12.18%

Cashflow Statement

Concept 2021 Q1 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $9.600M -$7.200M -$2.200M
YoY Change -233.33% 227.27% -131.43%
Depreciation, Depletion And Amortization $1.100M $1.100M $1.100M
YoY Change 0.0% 0.0% 0.0%
Cash From Operating Activities $32.10M $37.70M -$13.20M
YoY Change -14.85% -385.61% -73.65%
INVESTING ACTIVITIES
Capital Expenditures -$300.0K -$800.0K -$1.200M
YoY Change -62.5% -33.33% 50.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$118.0M $27.00M
YoY Change -100.0% -537.04% 27.36%
Cash From Investing Activities -$300.0K -$118.8M $25.70M
YoY Change -99.75% -562.26% 25.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.20M -3.900M -3.800M
YoY Change 392.31% 2.63% -1050.0%
NET CHANGE
Cash From Operating Activities 32.10M 37.70M -13.20M
Cash From Investing Activities -300.0K -118.8M 25.70M
Cash From Financing Activities -19.20M -3.900M -3.800M
Net Change In Cash 12.60M -85.00M 8.700M
YoY Change -114.82% -1077.01% -129.69%
FREE CASH FLOW
Cash From Operating Activities $32.10M $37.70M -$13.20M
Capital Expenditures -$300.0K -$800.0K -$1.200M
Free Cash Flow $32.40M $38.50M -$12.00M
YoY Change -15.84% -420.83% -75.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2021Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityNoncurrent
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000100591
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Entity Registrant Name
EntityRegistrantName
ARGAN INC
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-01-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-31756
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1947195
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
One Church Street, Suite 201
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Rockville
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20850
CY2021 dei City Area Code
CityAreaCode
301
CY2021 dei Local Phone Number
LocalPhoneNumber
315-0027
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.15 par value
CY2021 dei Trading Symbol
TradingSymbol
AGX
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 agx Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Public Float
EntityPublicFloat
416407005
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15720136
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
392206000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238997000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
482153000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
330139000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
245817000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
399715000
CY2021 us-gaap Gross Profit
GrossProfit
62067000
CY2020 us-gaap Gross Profit
GrossProfit
-6820000
CY2019 us-gaap Gross Profit
GrossProfit
82438000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39041000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44125000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40710000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4895000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1491000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
23026000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-55840000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
40237000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1859000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8075000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6981000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24885000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47765000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47218000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7053000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4651000
CY2021 us-gaap Profit Loss
ProfitLoss
23811000
CY2020 us-gaap Profit Loss
ProfitLoss
-40712000
CY2019 us-gaap Profit Loss
ProfitLoss
51869000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-40000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1977000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-167000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23851000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-42689000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
52036000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
35000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-770000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1768000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
23886000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-43459000
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
50268000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.52
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.73
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.34
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.73
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.32
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15668000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15621000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15569000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15825000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15621000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15693000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
3.00
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2019 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366671000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
167363000
CY2021Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
90055000
CY2020Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
160499000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28713000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37192000
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
26635000
CY2020Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
33379000
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
34146000
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
23322000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
546220000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
421755000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20361000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22539000
CY2021Q1 us-gaap Goodwill
Goodwill
27943000
CY2020Q1 us-gaap Goodwill
Goodwill
27943000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4097000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5001000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
249000
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7894000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3760000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2408000
CY2021Q1 us-gaap Assets
Assets
602630000
CY2020Q1 us-gaap Assets
Assets
487540000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
53295000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
35442000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50750000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
35907000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
172042000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
72685000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
276087000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
144034000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4135000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2476000
CY2021Q1 us-gaap Liabilities
Liabilities
280222000
CY2020Q1 us-gaap Liabilities
Liabilities
146510000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15706202
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15638202
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15702969
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15634969
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
2356000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
2346000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
153282000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
148713000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
166110000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
189306000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1081000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1116000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
320667000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
339249000
CY2021Q1 us-gaap Minority Interest
MinorityInterest
1741000
CY2020Q1 us-gaap Minority Interest
MinorityInterest
1781000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
322408000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
341030000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
602630000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
487540000
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
358128000
CY2019 us-gaap Profit Loss
ProfitLoss
51869000
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-1768000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1645000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
102000
CY2019 agx Cash Distribution To Joint Venture Partner
CashDistributionToJointVenturePartner
72000
CY2019 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15570000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
394372000
CY2020 us-gaap Profit Loss
ProfitLoss
-40712000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-770000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2131000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1630000
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15621000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
341030000
CY2021 us-gaap Profit Loss
ProfitLoss
23811000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
35000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2938000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1641000
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
47047000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
322408000
CY2021 us-gaap Profit Loss
ProfitLoss
23811000
CY2020 us-gaap Profit Loss
ProfitLoss
-40712000
CY2019 us-gaap Profit Loss
ProfitLoss
51869000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
1004000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8463000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1038000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7645000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6640000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2139000
CY2021 us-gaap Depreciation
Depreciation
3715000
CY2020 us-gaap Depreciation
Depreciation
3513000
CY2019 us-gaap Depreciation
Depreciation
3422000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2938000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2131000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1645000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1820000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
904000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1136000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1012000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4895000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1491000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-641000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-889000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
301000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10200000
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-6744000
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-24978000
CY2019 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
44510000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12800000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2357000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
15160000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
31442000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3284000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-60187000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
99357000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
64336000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-39264000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
174680000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53565000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-112322000
CY2021 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
170000000
CY2020 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
166000000
CY2019 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
370000000
CY2021 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
100000000
CY2020 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
195000000
CY2019 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
191000000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1697000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7058000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8599000
CY2019 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
-225000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
68303000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45406000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13991000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15540000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36058000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
170626000
CY2021 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
47047000
CY2020 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
15621000
CY2019 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
15570000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1641000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1630000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
102000
CY2019 agx Payments Of Distributions To Joint Venture Partners
PaymentsOfDistributionsToJointVenturePartners
72000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1731000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-471000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-553000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
199308000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3045000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42211000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167363000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
164318000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122107000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
366671000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167363000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
164318000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 8pt 0pt;"><i style="font-style:italic;">Use of Estimates</i> – The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues, expenses, and certain financial statement disclosures.  Management believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to it at the time that these estimates, judgments and assumptions are made. Estimates are used for, but are not limited to, the Company’s accounting for revenues, the valuation of assets with long and indefinite lives including goodwill, the valuation of restricted stock and options to purchase shares of the Company’s common stock, the evaluation of contingent obligations and uncertain income tax return positions, the valuation of deferred taxes, and the determination of the allowance for doubtful accounts. Actual results could differ from these estimates.</p>
CY2021Q1 agx Retained Amount Under Construction Contracts
RetainedAmountUnderConstructionContracts
36800000
CY2020Q1 agx Retained Amount Under Construction Contracts
RetainedAmountUnderConstructionContracts
20000000.0
CY2021Q1 agx N Priced Change Orders Included In Transaction Prices
NPricedChangeOrdersIncludedInTransactionPrices
16600000
CY2020Q1 agx N Priced Change Orders Included In Transaction Prices
NPricedChangeOrdersIncludedInTransactionPrices
20600000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
552500000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.64
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
392206000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238997000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
482153000
CY2021Q1 agx Invoices Outstanding Balance Included In Accounts Receivable And Contract Assets
InvoicesOutstandingBalanceIncludedInAccountsReceivableAndContractAssets
24500000
CY2021Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1800000
CY2021 us-gaap Goodwill Impairment Loss Net Of Tax
GoodwillImpairmentLossNetOfTax
0
CY2018Q1 us-gaap Goodwill
Goodwill
34329000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1491000
CY2019Q1 us-gaap Goodwill
Goodwill
32838000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4895000
CY2020Q1 us-gaap Goodwill
Goodwill
27943000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q1 us-gaap Goodwill
Goodwill
27943000
CY2021Q1 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
16400000
CY2021 agx Period Of Amortization Of Goodwill For Income Tax Purpose
PeriodOfAmortizationOfGoodwillForIncomeTaxPurpose
P15Y
CY2021Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11385000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7288000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4097000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5001000
CY2019 agx Additions To Other Intangible Assets
AdditionsToOtherIntangibleAssets
0
CY2020 agx Additions To Other Intangible Assets
AdditionsToOtherIntangibleAssets
0
CY2021 agx Additions To Other Intangible Assets
AdditionsToOtherIntangibleAssets
0
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000.0
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
870000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
617000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
392000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
392000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
376000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1450000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4097000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38723000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
37525000
CY2021 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1900000
CY2020 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
3400000
CY2019 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
3100000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18362000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14986000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20361000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22539000
CY2021 us-gaap Depreciation
Depreciation
3700000
CY2020 us-gaap Depreciation
Depreciation
3500000
CY2019 us-gaap Depreciation
Depreciation
3400000
CY2020Q1 agx Amount Outstanding Letter Of Credit Issued By Bank In Support Of Project Development Activities And Deposited In Bank As Collateral
AmountOutstandingLetterOfCreditIssuedByBankInSupportOfProjectDevelopmentActivitiesAndDepositedInBankAsCollateral
3400000
CY2021Q1 agx Amount Outstanding Letter Of Credit Issued By Bank In Support Of Project Development Activities And Deposited In Bank As Collateral
AmountOutstandingLetterOfCreditIssuedByBankInSupportOfProjectDevelopmentActivitiesAndDepositedInBankAsCollateral
3400000
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1800000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000.0
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1800000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1000000.0
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P30M
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.031
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2185000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
924000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
242000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
92000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
20000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3463000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
92000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3371000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2106000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1265000
CY2021Q1 agx Estimated Value Of Future Work Covered By Outstanding Performance Bonds
EstimatedValueOfFutureWorkCoveredByOutstandingPerformanceBonds
482000000
CY2021 agx Bonds Outstanding Covering Other Risks
BondsOutstandingCoveringOtherRisks
43000000
CY2021 agx Number Of Epc Services Projects.
NumberOfEPCServicesProjects.
4
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1900000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1700000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2400000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
889000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.83
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M28D
CY2018Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
11.74
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
257000
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
40.54
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6000
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
17.19
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1140000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.01
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M14D
CY2019Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
11.22
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
238000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44.76
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
26.67
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
46000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
48.47
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1271000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.83
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M4D
CY2020Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
11.06
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
242000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
37.26
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
68000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.17
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
40000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
57.44
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1405000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.17
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2021Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
10.39
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
823000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
45.58
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2020Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionExercisableWeightedAverageGrantDateFairValue
11.78
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
938000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
46.09
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M12D
CY2021Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionExercisableWeightedAverageGrantDateFairValue
11.58
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
302000
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
13.55
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
257000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.31
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
184000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
14.75
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
375000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
10.05
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
238000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.60
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
134000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
10.25
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
31000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
10.28
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
448000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
9.74
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
242000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.53
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
207000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
9.98
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
16000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
8.52
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
467000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
8.01
CY2021 agx Percentage Reduction In Aggregate Fair Value Of Stock Option
PercentageReductionInAggregateFairValueOfStockOption
0.885
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2900000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2100000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1600000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3600000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
7000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6100000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4100000
CY2021 agx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Period For Monthly Closing Prices
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeriodForMonthlyClosingPrices
P5Y
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-6654000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-77000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-3603000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
83000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-336000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1091000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-6571000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-413000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-2512000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
7720000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-6825000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-971000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-75000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
185000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1168000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7645000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6640000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2139000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7053000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4651000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5226000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10030000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
9916000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
421000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-81000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-683000
CY2021 agx Net Operating Loss Carryback Rate Difference Benefit Amount
NetOperatingLossCarrybackRateDifferenceBenefitAmount
4392000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15825000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
763000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
266000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
468000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-31000
CY2021 agx Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessExecutiveCompensationAmount
420000
CY2020 agx Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessExecutiveCompensationAmount
420000
CY2019 agx Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessExecutiveCompensationAmount
866000
CY2021 agx Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward Amount Utilization
EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforwardAmountUtilization
242000
CY2019 agx Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward Amount Utilization
EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforwardAmountUtilization
1730000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-173000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
722000
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-86000
CY2021 agx Effective Income Tax Rate Reconciliation Bad Debt Loss
EffectiveIncomeTaxRateReconciliationBadDebtLoss
-160000
CY2020 agx Effective Income Tax Rate Reconciliation Bad Debt Loss
EffectiveIncomeTaxRateReconciliationBadDebtLoss
-6205000
CY2020 agx Effective Income Tax Rate Reconciliation Net Operating Loss Benefits Elimination Amount
EffectiveIncomeTaxRateReconciliationNetOperatingLossBenefitsEliminationAmount
7239000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
13866000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-80000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
150000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
245000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7053000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4651000
CY2021 agx Income Tax Benefit Federal And State
IncomeTaxBenefitFederalAndState
6800000
CY2021 us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
-200000
CY2019 agx Current Research And Development State Tax Credit Benefits
CurrentResearchAndDevelopmentStateTaxCreditBenefits
2800000
CY2021 agx Increase In Loss Carryback Period For Certain Losses
IncreaseInLossCarrybackPeriodForCertainLosses
P5Y
CY2021Q1 agx Domestic Net Operating Loss Carryback
DomesticNetOperatingLossCarryback
39500000
CY2020Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8300000
CY2021Q1 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
12700000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 agx Net Operating Loss Carryback Rate Difference Benefit Amount
NetOperatingLossCarrybackRateDifferenceBenefitAmount
4400000
CY2021 agx Period For Identify And Quantify Research And Development Tax Credits
PeriodForIdentifyAndQuantifyResearchAndDevelopmentTaxCredits
P3Y
CY2021Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16600000
CY2019Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
400000
CY2020Q4 agx Unrecognized Income Tax Benefits Related To Research And Development Credits
UnrecognizedIncomeTaxBenefitsRelatedToResearchAndDevelopmentCredits
5000000.0
CY2020Q4 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
26900000
CY2020Q1 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
14500000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
23851000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-42689000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
52036000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15668000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15621000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15569000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
157000
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
124000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4895000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-55840000
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14192000
CY2020Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22683000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2549000
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2367000
CY2021Q1 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
102000
CY2020Q1 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
134000
CY2021Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
234000
CY2020Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
415000
CY2021Q1 agx Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
775000
CY2020Q1 agx Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
528000
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1422000
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
991000
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19274000
CY2020Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
27118000
CY2021Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3513000
CY2020Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3317000
CY2021Q1 agx Deferred Tax Liabilities Construction Contracts
DeferredTaxLiabilitiesConstructionContracts
968000
CY2020Q1 agx Deferred Tax Liabilities Construction Contracts
DeferredTaxLiabilitiesConstructionContracts
1618000
CY2021Q1 agx Deferred Tax Liabilities Property Plant And Equipment And Other
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndOther
1801000
CY2020Q1 agx Deferred Tax Liabilities Property Plant And Equipment And Other
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndOther
1983000
CY2021Q1 agx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
770000
CY2020Q1 agx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
525000
CY2021Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
176000
CY2020Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
193000
CY2021Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7228000
CY2020Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7636000
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11797000
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11588000
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
249000
CY2020Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7894000
CY2021Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6300000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5500000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3100000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3900000
CY2021 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
1000000.0
CY2020 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
8400000
CY2019 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.73
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.32
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
638001
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
646500
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1303000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8075000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47765000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7053000
CY2020 us-gaap Profit Loss
ProfitLoss
-40712000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1136000
CY2020 us-gaap Depreciation
Depreciation
3513000
CY2020 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
7058000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15621000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15693000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.52
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.73
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.34
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2020Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2020Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2020Q3 agx Common Stock Special Dividends Per Share Cash Paid
CommonStockSpecialDividendsPerShareCashPaid
1.00
CY2020Q4 agx Common Stock Special Dividends Per Share Cash Paid
CommonStockSpecialDividendsPerShareCashPaid
1.00
CY2019 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2020 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
392206000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
330139000
CY2021 us-gaap Gross Profit
GrossProfit
62067000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39041000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
23026000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1859000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24885000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2021 us-gaap Profit Loss
ProfitLoss
23811000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
904000
CY2021 us-gaap Depreciation
Depreciation
3715000
CY2021 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1697000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
546220000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
276087000
CY2021Q1 us-gaap Goodwill
Goodwill
27943000
CY2021Q1 us-gaap Assets
Assets
602630000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238997000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
245817000
CY2020 us-gaap Gross Profit
GrossProfit
-6820000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44125000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
40237000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6981000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47218000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4651000
CY2019 us-gaap Profit Loss
ProfitLoss
51869000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1012000
CY2019 us-gaap Depreciation
Depreciation
3422000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
421755000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
144034000
CY2020Q1 us-gaap Goodwill
Goodwill
27943000
CY2020Q1 us-gaap Assets
Assets
487540000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
482153000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
399715000
CY2019 us-gaap Gross Profit
GrossProfit
82438000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40710000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1491000
CY2019 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
8599000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
416348000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
81316000
CY2019Q1 us-gaap Goodwill
Goodwill
32838000
CY2019Q1 us-gaap Assets
Assets
476648000

Files In Submission

Name View Source Status
0001558370-21-004282-index-headers.html Edgar Link pending
0001558370-21-004282-index.html Edgar Link pending
0001558370-21-004282.txt Edgar Link pending
0001558370-21-004282-xbrl.zip Edgar Link pending
agx-20210131.xsd Edgar Link pending
agx-20210131x10k.htm Edgar Link pending
agx-20210131x10k001.jpg Edgar Link pending
agx-20210131x10k002.jpg Edgar Link pending
agx-20210131x10k_htm.xml Edgar Link completed
agx-20210131xex21.htm Edgar Link pending
agx-20210131xex23d1.htm Edgar Link pending
agx-20210131xex31d1.htm Edgar Link pending
agx-20210131xex31d2.htm Edgar Link pending
agx-20210131xex32d1.htm Edgar Link pending
agx-20210131xex32d2.htm Edgar Link pending
agx-20210131_cal.xml Edgar Link unprocessable
agx-20210131_def.xml Edgar Link unprocessable
agx-20210131_lab.xml Edgar Link unprocessable
agx-20210131_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending